Diabetes is an autoimmune disease that compromises the body's production of insulin. Type 1 diabetes (insulin-dependent diabetes) usually occurs in younger individuals, and makes up less than 15% of all cases of diabetes. Type 2 diabetes (insulin-resistant diabetes) is much more common, and tends to affect people over the age of 30.
Research into probiotics and their effects on patients with diabetes remains relatively sparse. Many people believe that probiotics can be beneficial for diabetics, as probiotic bacteria improves immunity and should therefore help to correct autoimmune diseases such as diabetes. Furthermore evidence suggests that the use of probiotics may lower the risk contracting diabetes.
Research on probiotics and Type 2 diabetes continues to suggest that probiotics can help weight control in patients who are insulin-resistant.
However, as there is possibility that probiotics could improve sugar utilisation in the body; whilst research remains inconclusive we do not recommend OptiBac Probiotics to people with insulin-dependent (Type 1) diabetes.
